Browse > Article
http://dx.doi.org/10.5352/JLS.2013.23.2.207

Resveratrol Up-regulates Cysteine-rich Angiogenic Inducer 61 (CYR61) in Human Colorectal Cancer Cells  

Kwak, Eun-Hee (Department of Biological Sciences, Andong National University)
Kim, Jong-Sik (Department of Biological Sciences, Andong National University)
Publication Information
Journal of Life Science / v.23, no.2, 2013 , pp. 207-212 More about this Journal
Abstract
In this paper, we investigated whether resveratrol could induce the expression of cysteine-rich angiogenic inducer 61 (CYR61), which is a member of the CCN families. We showed that resveratrol up-regulated CYR61 protein expression in three different human colorectal cancer cell lines. In addition, resveratrol induced CYR61 protein expression in a dose- and time-dependent manner in a HCT116 cell line. To investigate the relationship between various biological activities of resveratrol and CYR61 expression, HCT116 cells were incubated with several NSAIDs, antioxidants, or resveratrol. Interestingly, resveratrol only induced CYR61 protein expression. The expression of CYR61 was not related to the presence of p53. A promoter assay revealed that the 786-bp promoter region (-732/+54) contains a regulatory region and that indole-3-carbinol and 6-gingerol could not induce CYR61 expression. In conclusion, our results indicate up-regulation of CYR61 is extremely resveratrol specific. The results can help to shed light on the unique biological function of resveratrol.
Keywords
Resveratrol; CYR61; human colorectal cancer cell; luciferase assay;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Baek, S. J., Wilson, L. C. and Eling, T. E. 2002. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23, 425-434.   DOI   ScienceOn
2 Bavaresco, L. 2003. Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs Exp Clin Res 29, 181-187.
3 Brigstock, D. R. 2003. The CCN family: a new stimulus package. J Endocrinol 178, 169-175.   DOI
4 Chien, W., Kumagai, T., Miller, C. W., Desmond, J. C., Frank, J. M., Said, J. W. and Koeffler, H. P. 2004. Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279, 53087-53096.   DOI   ScienceOn
5 Chung, E. Y., Kim, B. H., Hong, J. T., Lee, C. K., Ahn, B., Nam, S. Y., Han, S. B. and Kim, Y. 2011. Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. J Nutr Biochem 22, 902-909.   DOI   ScienceOn
6 Chuang, J. Y., Yu, N. Y., Chiang, I. P., Lai, C. H., Lin, C. D. and Tang, C. H. 2012. Cyr61 increases matrix metalloproteinase- 3 expression and cell motility in human oral squamous cell carcinoma cells. J Cell Biochem 113, 1977-1986.   DOI   ScienceOn
7 Delmas, D., Lançon, A., Colin, D., Jannin, B. and Latruffe, N. 2006. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 7, 423-442.   DOI   ScienceOn
8 Dhar, A. and Ray, A. 2010. The CCN family proteins in carcinogenesis. Exp Oncol 32, 2-9.
9 Kim, J. S., Jang, M. J., Kim, H. Y., Kim, S. Y. and Sohn, H. Y. 2007. Analysis of differentially expressed genes by resveratrol using membrane microarray. J Life Sci 17, 1115-1120.   과학기술학회마을   DOI   ScienceOn
10 Kim, Y. A., Lee, W. H., Choi, T. H., Rhee, S. H., Park, K. Y. and Choi, Y. H. 2003. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells. Int J Oncol 23, 1143-1149.
11 O'Kelly, J., Chung, A., Lemp, N., Chumakova, K., Yin, D., Wang, H. J., Said, J., Gui, D., Miller, C. W., Karlan, B. Y. and Koeffler, H. P. 2008. Functional domains of CCN1 (Cyr61) regulate breast cancer progression. Int J Oncol 33, 59-67.
12 Park, M. H., Kwak, E. H., Sohn, H. Y., Eling, T. E. and Kim, J. S. 2011. Global gene expression changes by several phytochemicals in human colorectal cancer cell. J Life Sci 21, 1219-1225.   과학기술학회마을   DOI   ScienceOn
13 Perbal, B. 2004. CCN proteins: multifunctional signalling regulators. Lancet 363, 62-64.   DOI   ScienceOn
14 Rayalam, S., Yang, J. Y., Ambati, S., Della-Fera, M. A. and Baile, C. A. 2008. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res 22, 1367-1371.   DOI   ScienceOn
15 Rizvi, S. I. and Pandey, K. B. 2010. Activation of the erythrocyte plasma membrane redox system by resveratrol: a possible mechanism for antioxidant properties. Pharmacol Rep 62, 726-732.   DOI   ScienceOn
16 Tong, X., O'Kelly, J., Xie, D., Mori, A., Lemp, N., McKenna, R., Miller, C. W. and Koeffler, H. P. 2004. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta- catenin-c-myc-p53 pathway. Oncogene 23, 4847-4855.   DOI   ScienceOn
17 Whitlock, N. C., Bahn, J. H., Lee, S. H., Eling, T. E. and Baek, S. J. 2011. Resveratrol-induced apoptosis is mediated by early growth response-1, Krüppel-like factor 4, and activating transcription factor 3. Cancer Prev Res (Phila) 4, 116-127.   DOI   ScienceOn
18 Udenigwe, C. C., Ramprasath, V. R., Aluko, R. E. and Jones, P. J. 2008. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 66, 445-454.   DOI   ScienceOn
19 Vogelstein, B., Lane, D. and Levine, A. J. 2000. Surfing the p53 network. Nature 408, 307-310.   DOI   ScienceOn